Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Neutral Rating on AvalonBay Communities with Lowered Price Target

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Real Estate Investment Markets and money
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Vikram Malhotra, an analyst at Mizuho, has decided to keep a Neutral rating on AvalonBay Communities (NYSE: AVB) and has slightly decreased the price target to $185 from $188. This adjustment follows a recent increase in the price target from $176 to $188 on January 10th. It is important to mention that the average 12-month price target for AvalonBay Communities is currently $194.2, as indicated by evaluations from 10 financial analysts.

AvalonBay Communities Inc. (AVB) Stock Sees Slight Increase on February 28, 2024: Factors Investors Should Consider

On February 28, 2024, AvalonBay Communities Inc. (AVB) saw a slight increase in its stock performance. The stock closed at $174.37, marking a $0.75 increase from the previous market close, representing a 0.43% rise. Additionally, in after-hours trading, the stock continued to climb, rising by an additional $0.54.

Investors may want to consider the factors contributing to AVB’s recent price momentum. This could include company-specific news, industry trends, or broader market conditions. By staying informed and conducting thorough research, investors can make more informed decisions about their investment strategies.

AVB Stock Reports Mixed Performance in 2024 with Revenue Growth and Net Income Decrease

AVB stock had a mixed performance on February 28, 2024, as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, AVB’s total revenue for the year stood at $2.82 billion, representing a 7.04% increase from the previous year. However, total revenue for the fourth quarter was reported at $718.65 million, remaining flat compared to the previous quarter. AVB’s net income for the year was $927.16 million, marking an 18.29% decrease from the previous year. However, net income for the fourth quarter was $241.53 million, showing a significant increase of 40.65% from the previous quarter. Earnings per share (EPS) for the year were reported at $6.55, reflecting a 19.25% decrease from the previous year. EPS for the fourth quarter remained flat at $1.70. Investors and analysts will likely be closely monitoring AVB’s performance in the coming quarters to see if the company can sustain its revenue growth and improve its profitability.

Tags: AVB
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Assets (2)

Analyst Maintains Neutral Rating on Equity Residential with Adjusted Price Target

Real Estate Investment Markets and money

Analysts Maintain Neutral Rating on MidAmerica Apartment Communities with Adjusted Price Targets

Finance_Assets (2)

Ambarellas Stock Soars After Exceeding Expectations in Q4 FY24

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com